Catalyst Wire Dossier Catalyst Wire Dossier

5-ALA (5-aminolevulinic acid) for photodynamic therapy

5-aminolevulinic acid
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 5-ALA (5-aminolevulinic acid) for photodynamic therapy, covering 2025-09-25 to 2025-09-25. Get the full timeline:

Most recent: Clinical Trial Update: The IMmunotherapy Pleural 5-ALA PDT [Phase 2]

See pricing